Table 1—

Characteristics of participating studies*

Cohort nameCountrynAge (years)Females (%)Diabetes (%)Median follow-up (years)Fatal events
Nonfatal events
AllCVDCHDStrokeMIStroke
Asia
  AitoJapan1,71820–7756.72.715.2181591625
  AkabaneJapan1,82840–6955.71.411.0137367122126
  CISCHChina2,16334–6450.92.53.37110149
  Civil ServiceJapan9,31840–5533.11.86.7991312
  East BeijingChina1,13520–8451.25.617.1121652028
  Hong KongHong Kong2,96066–10757.28.62.56321978372
  Kinmen IslandTaiwan2,52250–9348.98.72.9165961012
  KonanJapan1,22620–9655.43.06.48226313
  MiyamaJapan1,07140–8055.85.06.69026210
  OhasamaJapan2,24027–9163.810.04.188277848
  SaitamaJapan3,62420–9462.21.710.33651202455
  Seven CitiesChina37,35335–9853.11.12.581147278173145
  ShibataJapan2,35040–8957.71.120.083334667209
  ShigarakiJapan3,75729–9459.55.44.411729313
  Singapore HeartSingapore2,36820–8948.99.514.61675931213968
  Singapore 92Singapore3,33220–7051.89.66.271332261541
  Tanno/SoubetsuJapan1,95739–6553.46.216.42477223330
  CVD FACTTaiwan5,72920–9255.42.76.0230601329
  YunnanChina6,57035–843.10.54.563022017106
    Subtotal93,22120–10748.72.94.65,0731,95742882789337
Australasia
  BusseltonAustralia5,28320–9651.81.917.51,674897506193326336
  CanberraAustralia87970–9747.26.87.73911055523
  Fletcher ChallengeNew Zealand10,32620–8928.12.54.823011070167174
  Melbourne CancerAustralia41,28627–7558.93.75.61,09625416132
  PerthAustralia10,21920–9048.32.114.481331219463
    Subtotal67,99320–9751.93.25.64,2041,678986327397410
Total161,21420–10750.03.05.49,2773,6351,4141,154486747
  • *

    * Restricted to studies and subjects with information on history of diabetes at baseline and duration of follow-up. CHD, coronary heart disease; CVD, total cardiovascular disease; MI, myocardial infarction.